The prognostic role of Claudin 18.2 in advanced gastric or gastroesophageal junction adenocarcinoma: a systematic literature review
Claudin 18 isoform 2 (CLDN18.2) is a tight junction protein expressed in normal gastric tissue and retained in gastric or gastroesophageal junction (G/GEJ) adenocarcinoma. The phase III trials SPOTLIGHT and GLOW demonstrated improved survival following the addition of the CLDN18.2-targeted antibody...
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-09-01
|
Series: | ESMO Gastrointestinal Oncology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2949819825000792 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!